92.10
+0.30
+(0.33%)
At close: 1:30:25 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,215,286.00
1,114,687.00
986,300.00
893,233.00
983,788.00
Cost of Revenue
762,852.00
705,166.00
618,302.00
601,881.00
612,875.00
Gross Profit
452,434.00
409,521.00
367,998.00
291,352.00
370,913.00
Operating Expense
133,410.00
127,632.00
129,769.00
122,766.00
108,541.00
Operating Income
319,024.00
281,889.00
238,229.00
168,586.00
262,372.00
Net Non Operating Interest Income Expense
20,336.00
23,992.00
10,094.00
-1,133.00
2,719.00
Pretax Income
409,577.00
313,769.00
355,237.00
200,229.00
232,909.00
Tax Provision
82,096.00
62,756.00
59,949.00
23,069.00
46,167.00
Net Income Common Stockholders
327,481.00
251,013.00
295,288.00
177,160.00
186,742.00
Diluted NI Available to Com Stockholders
327,481.00
251,013.00
295,288.00
177,160.00
186,742.00
Basic EPS
7.34
5.63
6.62
5.03
6.21
Diluted EPS
7.33
5.62
6.61
5.02
6.20
Basic Average Shares
44,612.37
44,584.90
44,605.44
35,249.00
30,060.00
Diluted Average Shares
44,675.00
44,664.24
44,672.92
35,284.00
30,111.00
Total Expenses
896,262.00
832,798.00
748,071.00
724,647.00
721,416.00
Net Income from Continuing & Discontinued Operation
327,481.00
251,013.00
295,288.00
177,160.00
186,742.00
Normalized Income
327,481.00
251,043.40
295,288.00
177,160.00
186,742.00
Interest Income
23,931.00
29,730.00
16,014.00
2,258.00
6,223.00
Interest Expense
3,595.00
5,738.00
5,920.00
3,391.00
3,504.00
Net Interest Income
20,336.00
23,992.00
10,094.00
-1,133.00
2,719.00
EBIT
413,172.00
319,507.00
361,157.00
203,620.00
236,413.00
EBITDA
554,100.00
431,261.00
442,005.00
275,072.00
307,185.00
Reconciled Cost of Revenue
762,852.00
705,166.00
618,302.00
601,881.00
612,875.00
Reconciled Depreciation
140,928.00
111,754.00
80,848.00
71,452.00
70,772.00
Net Income from Continuing Operation Net Minority Interest
327,481.00
251,013.00
295,288.00
177,160.00
186,742.00
Total Unusual Items Excluding Goodwill
--
-38.00
--
--
--
Total Unusual Items
--
-38.00
--
--
--
Normalized EBITDA
554,100.00
431,299.00
442,005.00
275,072.00
307,185.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
--
-7.60
--
--
--
12/31/2020 - 12/31/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
8279.TWO Syngen Biotech Co.,Ltd.
124.50
0.00%
3118.TWO Level Biotechnology Inc.
32.35
-0.15%
4728.TWO Sunmax Biotechnology Co., Ltd.
275.00
+0.18%
4911.TWO G&E Herbal Biotechnology Co., Ltd.
54.70
+0.92%
4131.TWO NeoCore Technology Co., Ltd.
31.00
0.00%
6733.TWO BioGend Therapeutics Co., Ltd.
33.00
0.00%
6461.TWO Intech Biopharm Corporation
24.85
+0.20%
3205.TWO Sagittarius Life Science Corp
33.95
-1.59%
4168.TWO GlycoNex Incorporation
24.00
0.00%
3176.TWO Medigen Biotechnology Corp.
32.60
-1.21%